Literature DB >> 17634408

Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma.

David González1, Mirjam van der Burg, Ramón García-Sanz, James A Fenton, Anton W Langerak, Marcos González, Jacques J M van Dongen, Jesus F San Miguel, Gareth J Morgan.   

Abstract

The ability to rearrange the germ-line DNA to generate antibody diversity is an essential prerequisite for the production of a functional repertoire. While this is essential to prevent infections, it also represents the "Achilles heel" of the B-cell lineage, occasionally leading to malignant transformation of these cells by translocation of protooncogenes into the immunoglobulin (Ig) loci. However, in evolutionary terms this is a small price to pay for a functional immune system. The study of the configuration and rearrangements of the Ig gene loci has contributed extensively to our understanding of the natural history of development of myeloma. In addition to this, the analysis of Ig gene rearrangements in B-cell neoplasms provides information about the clonal origin of the disease, prognosis, as well as providing a clinical useful tool for clonality detection and minimal residual disease monitoring. Herein, we review the data currently available on both Ig gene rearrangements and protein patterns seen in myeloma with the aim of illustrating how this knowledge has contributed to our understanding of the pathobiology of myeloma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634408     DOI: 10.1182/blood-2007-02-069625

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

Review 1.  LKB1 signaling in advancing cell differentiation.

Authors:  Lina Udd; Tomi P Mäkelä
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

2.  The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.

Authors:  Eva Martinez-Garcia; Relja Popovic; Dong-Joon Min; Steve M M Sweet; Paul M Thomas; Leonid Zamdborg; Aaron Heffner; Christine Will; Laurence Lamy; Louis M Staudt; David L Levens; Neil L Kelleher; Jonathan D Licht
Journal:  Blood       Date:  2010-10-25       Impact factor: 22.113

3.  Tumorigenic potential and disease manifestations of malignant B-cell variants differing in their fibronectin adhesiveness.

Authors:  Liat Nadav; Vyacheslav Kalchenko; Meir Max Barak; Elizabeth Naparstek; Benjamin Geiger; Ben-Zion Katz
Journal:  Exp Hematol       Date:  2008-08-09       Impact factor: 3.084

Review 4.  Monitoring minimal residual disease in the bone marrow using next generation sequencing.

Authors:  Even H Rustad; Eileen M Boyle
Journal:  Best Pract Res Clin Haematol       Date:  2020-01-17       Impact factor: 3.020

5.  Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma.

Authors:  S Kumar; L Zhang; A Dispenzieri; S Van Wier; J A Katzmann; M Snyder; E Blood; R DeGoey; K Henderson; R A Kyle; A R Bradwell; P R Greipp; S V Rajkumar; R Fonseca
Journal:  Leukemia       Date:  2010-06-03       Impact factor: 11.528

Review 6.  Toward personalized treatment in multiple myeloma based on molecular characteristics.

Authors:  Charlotte Pawlyn; Faith E Davies
Journal:  Blood       Date:  2018-12-26       Impact factor: 22.113

7.  Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes.

Authors:  Simone Ferrero; Daniela Capello; Mirija Svaldi; Michela Boi; Daniela Gatti; Daniela Drandi; Davide Rossi; Sara Barbiero; Barbara Mantoan; Elisabetta Mantella; Manuela Zanni; Paola Ghione; Alessandra Larocca; Roberto Passera; Francesco Bertoni; Valter Gattei; Francesco Forconi; Luca Laurenti; Giovanni Del Poeta; Roberto Marasca; Sergio Cortelazzo; Gianluca Gaidano; Antonio Palumbo; Mario Boccadoro; Marco Ladetto
Journal:  Haematologica       Date:  2011-12-29       Impact factor: 9.941

8.  Evaluation diagnostic usefulness of immunoglobulin light chains (Igκ, Igλ) and incomplete IGH D-J clonal gene rearrangements in patients with B-cell non-Hodgkin lymphomas using BIOMED-2 protocol.

Authors:  S Ghorbian; I Jahanzad; G R Javadi; E Sakhinia
Journal:  Clin Transl Oncol       Date:  2014-05-27       Impact factor: 3.405

Review 9.  Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas.

Authors:  Marta-Isabel Pereira; José Augusto Medeiros
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

10.  Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.

Authors:  Shahanawaz Jiwani; Joshua Bornhost; Daisy Alapat
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.